McIntyre, MD: GLP-1 agonists for psychiatry
Functional and Clinical Relevance of Novel and Known PCSK1 Variants for Childhood Obesity and Glucose Metabolism. Molecular Metabolism, vol
Aging 13 , 38983908 (2021)
Related Blog Posts Transforming Lives, One Step at a Time Keep reading Mons Pubis Fat Loss on GLP-1s: The Pubic Area Change Nobody Mentions One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone, How to Adjust Weight Loss Goals on GLP-1 Medications Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing
On a standard 1 mg Ozempic pen, this specific dose is achieved by u003ca href=u0022#using-the-semaglutide-click-methodu0022u003eturning the dialu003c/au003e roughly 9 clicks, which is around half of the standard medical starting dose of 0.25 mg
We recommend a mix of clinician competence and patient responsibility